ATE485037T1 - Krebsbehandlung mittels fts und 2-deoxyglucose - Google Patents

Krebsbehandlung mittels fts und 2-deoxyglucose

Info

Publication number
ATE485037T1
ATE485037T1 AT06844276T AT06844276T ATE485037T1 AT E485037 T1 ATE485037 T1 AT E485037T1 AT 06844276 T AT06844276 T AT 06844276T AT 06844276 T AT06844276 T AT 06844276T AT E485037 T1 ATE485037 T1 AT E485037T1
Authority
AT
Austria
Prior art keywords
fts
deoxyglucose
cancer treatment
analogs
disclosed
Prior art date
Application number
AT06844276T
Other languages
English (en)
Inventor
Yoel Kloog
Liat Goldberg
Michael Brownstein
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of ATE485037T1 publication Critical patent/ATE485037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT06844276T 2005-11-28 2006-11-06 Krebsbehandlung mittels fts und 2-deoxyglucose ATE485037T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74009605P 2005-11-28 2005-11-28
PCT/US2006/043325 WO2007064448A2 (en) 2005-11-28 2006-11-06 Cancer treatment using fts and 2-deoxyglucose

Publications (1)

Publication Number Publication Date
ATE485037T1 true ATE485037T1 (de) 2010-11-15

Family

ID=38016969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06844276T ATE485037T1 (de) 2005-11-28 2006-11-06 Krebsbehandlung mittels fts und 2-deoxyglucose

Country Status (5)

Country Link
US (1) US8278349B2 (de)
EP (1) EP1957060B1 (de)
AT (1) ATE485037T1 (de)
DE (1) DE602006017728D1 (de)
WO (1) WO2007064448A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778209B8 (de) 2004-08-18 2010-06-16 Concordia Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur oralen fts-abgabe
DE602006017728D1 (de) 2005-11-28 2010-12-02 Univ Ramot Krebsbehandlung mittels fts und 2-deoxyglucose
US20100130434A1 (en) * 2006-02-24 2010-05-27 Board Of Regents, The University Of Texas System Hexose Compounds to Treat Cancer
MX2009006574A (es) 2006-12-19 2009-07-02 Univ Ramot Tratamiento de cancer de pulmon.
CA2723197C (en) 2008-05-02 2017-09-19 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
JP2013508458A (ja) * 2009-10-26 2013-03-07 ラモット・アット・テル−アヴィヴ・ユニヴァーシティ・リミテッド Ｆｔｓとｈｄａｃ阻害剤との組合せを用いたがん治療
KR20190022884A (ko) 2010-08-05 2019-03-06 시애틀 지네틱스, 인크. 푸코스 유사체를 사용한 생체 내에서의 단백질 푸코실화 억제 방법
JP6165744B2 (ja) 2011-10-07 2017-07-19 パイシーズ セラピューティックス エルエルシーＰｉｓｃｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｌｃ Ｒａｓアンタゴニストによる悪性および非悪性疾患の治療
US9738614B2 (en) 2011-10-07 2017-08-22 Pisces Therapeutics, Llc Malignant and non-malignant disease treatment with Ras antagonists
EP2887947B1 (de) 2012-08-23 2019-06-05 Seattle Genetics, Inc. Fukoseanaloga zur behandlung der sichelzellenanämie
WO2016061583A1 (en) * 2014-10-17 2016-04-21 University Of Virginia Patent Foundation Compositions and methods for treating pituitary tumors
CN110615891B (zh) * 2019-08-16 2020-06-23 河南大学 一类茄呢基硫代水杨酸化合物、其制备方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107587A (en) 1993-11-12 1998-08-16 Univ Ramot Farnesyl geranyl or geranyl-geranyl derivatives pharmaceutical compositions containing them and methods for their preparation
JP2003502365A (ja) * 1999-06-18 2003-01-21 サイリオス・コーポレイション Ｒａｓアンタゴニストによる非悪性疾患処置
US6670330B1 (en) 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
JP2006515883A (ja) 2003-01-10 2006-06-08 スレッシュオールド ファーマシューティカルズ， インコーポレイテッド ２−デオキシグルコースによる癌の処置
EP1778209B8 (de) * 2004-08-18 2010-06-16 Concordia Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur oralen fts-abgabe
DE602006017728D1 (de) 2005-11-28 2010-12-02 Univ Ramot Krebsbehandlung mittels fts und 2-deoxyglucose
WO2007091241A1 (en) 2006-02-10 2007-08-16 Ramot At Tel Aviv University Ltd. Treatment of ovarian cancer
MX2008013017A (es) 2006-04-11 2008-11-27 Univ Ramot Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl.
MX2009006574A (es) 2006-12-19 2009-07-02 Univ Ramot Tratamiento de cancer de pulmon.

Also Published As

Publication number Publication date
WO2007064448A3 (en) 2007-08-23
EP1957060B1 (de) 2010-10-20
DE602006017728D1 (de) 2010-12-02
WO2007064448A2 (en) 2007-06-07
US8278349B2 (en) 2012-10-02
US20090286870A1 (en) 2009-11-19
EP1957060A2 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
ATE485037T1 (de) Krebsbehandlung mittels fts und 2-deoxyglucose
CY1125292T1 (el) Παραγωγα 6,7,8,9-tetpaϋδpo-3h-πypazoλo[4,3-f iσοκινολινης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
EA201490254A1 (ru) Комбинированное лечение гепатита с
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
BRPI0611705A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
ATE557015T1 (de) 3,4-diarylpyrazole als proteinkinaseinhibitoren
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
EA201000091A1 (ru) ПРОИЗВОДНЫЕ МОРФОЛИНОПИРИМИДИНА, ИСПОЛЬЗУЕМЫЕ ПРИ ЗАБОЛЕВАНИЯХ, СВЯЗАННЫХ С mTOR КИНАЗОЙ И/ИЛИ PI3K
ATE531263T1 (de) Hemmer der bruton-tyrosinkinase
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
ATE543492T1 (de) Behandlung von lungenkrebs
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties